Procore stock price target raised to $90 from Goldman Sachs on stabilizing growth
Cintas Corp (NASDAQ:CTAS) reported the results of its 2025 Annual Meeting of Shareholders, held Tuesday, according to a statement released through a Securities and Exchange Commission filing.
Shareholders elected all nominated directors to the board. The directors elected and their respective votes in favor were Melanie W. Barstad (330,015,653 shares), Beverly K. Carmichael (339,446,916), Karen L. Carnahan (338,267,361), Robert E. Coletti (335,332,996), Scott D. Farmer (331,552,683), Martin Mucci (337,584,609), Joseph Scaminace (306,834,407), Todd M. Schneider (342,749,858), and Ronald W. Tysoe (329,266,100). Each nominee received more votes in favor than against.
Shareholders also approved, on an advisory basis, the compensation of the company’s named executive officers. The proposal received 330,468,757 votes for, 17,948,211 against, and 682,774 abstentions.
In addition, shareholders ratified the selection of Ernst & Young LLP as Cintas’ independent registered public accounting firm for fiscal 2026. The ratification received 347,180,490 votes for, 20,554,869 against, and 258,840 abstentions.
A shareholder proposal regarding the ability to call special shareholder meetings did not pass. Voting results showed 157,690,015 shares in favor, 190,386,157 against, and 1,023,570 abstentions.
The information in this article is based on a statement provided in a Securities and Exchange Commission filing.
In other recent news, Cintas Corporation has reported its first-quarter fiscal 2026 earnings, which surpassed analysts’ expectations. The company achieved an earnings per share of $1.20, slightly above the forecasted $1.19, and revenue reached $2.72 billion, exceeding the anticipated $2.7 billion. Additionally, Cintas announced a quarterly cash dividend of $0.45 per share, payable on December 15, 2025, to shareholders of record as of November 14, 2025. The company also revealed a new share repurchase program, authorizing the buyback of up to $1 billion of its common stock at market prices. This new program supplements an existing one, bringing the total potential repurchase authorization to $1.7 billion. Despite these positive developments, Cintas experienced a decline in its stock, with a premarket drop following a previous session decrease. These recent developments provide investors with important insights into the company’s financial health and strategic decisions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.